reviewCancer Treatment ReviewsNov 26, 2017GREEN OA

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy

RTRyuma TokunagaWZWu ZhangMNMadiha NaseemAPAlberto PucciniMDMartin D. Berger

University of Southern California · Kumamoto University

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,616
total citations
FWCI
26.75
Percentile
100%
References
102
Citations per year

Authors

9

Topics & keywords

Topics
Keywords
  • CXCL9
  • Medicine
  • CXCR3
  • CXCL10
  • Immune system
  • CXCL11
  • Chemokine
  • Cancer research
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.